Sign in

CIK 0001788028

  • Non-accelerated filer
  • Smaller reporting company

Jasper Therapeutics, Inc.

Sign in to watch
Ticker
JSPR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
842984849
Phone
+1 650-549-1400
Business address
2200 BRIDGE PKWY SUITE #102, REDWOOD CITY, CA, 94065
Former names
Amplitude Healthcare Acquisition Corp
  1. 4 Shares withheld for taxes See Remarks gave up 37,126 shares (to pay taxes)
  2. 4 Open-market sale Director sold 8,500 shares at $1.44 ($12,240)
  3. 4 Open-market buy 10% owner bought 2,666,666 shares at $1.50 ($3,999,999)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 3/A Insider 3/A
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market buy 10% owner bought 3,133,333 shares at $1.50 ($4,700,000)
  12. 4 Open-market sale 10% owner sold 75,000 shares at $1.89 ($141,750)
  13. 4 Grant or award President, CEO and Director acquired 506,250 shares (grant or award)
  14. 4 Grant or award Director acquired 24,500 shares (grant or award)
  15. 4 Grant or award Director acquired 30,250 shares (grant or award)
  16. 4 Grant or award Director acquired 29,500 shares (grant or award)
  17. 4 Grant or award See Remarks acquired 214,722 shares (grant or award)
  18. 4 Grant or award Director acquired 32,500 shares (grant or award)
  19. 4 Grant or award Director acquired 29,500 shares (grant or award)
  20. 4 Grant or award Director acquired 30,750 shares (grant or award)

Page 5 of 8 · 158 filings